About
Oral Biotherapeutics for GI Health
Areas of Focus
Categories
Biologics & BiopharmaceuticalDrug Delivery & FormulationSan Diego & Southern California
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
280
By Phase
PHASE1/PHASE2: 1PHASE1: 3
By Status
NOT_YET_RECRUITING: 3COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07107204Lead Sponsor
A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies
PHASE1/PHASE2Not yet recruiting
116 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2028
NCT07110363Lead Sponsor
A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer
PHASE1Not yet recruiting
58 participants
Started: Aug 31, 2025 · Completed: May 31, 2027
NCT07107178Lead Sponsor
A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma
PHASE1Not yet recruiting
58 participants
Started: Aug 8, 2025 · Completed: Aug 31, 2027
NCT06275464Lead Sponsor
BT-600 Single and Multiple Ascending Oral Doses in Healthy Adult Subjects
PHASE1Completed
48 participants
Started: Jan 11, 2024 · Completed: Apr 23, 2024
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...